Search Results - "Asensio López, M C"

Temporal characterization of cardiac expression of glucose transporters SGLT and GLUT in an experimental model of myocardial infarction by Sánchez-Más, J., Saura-Guillén, E., Asensio-López, M.C., Soriano-Filiu, Á., Carmen Sánchez-Pérez, M., Hernandez-Martinez, A.M., Lax, A., Pascual-Figal, D.

Get full text

Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction by Asensio-Lopez, M.C., Lax, A., Fernandez del Palacio, M.J., Sassi, Y., Hajjar, R.J., Januzzi, J.L., Bayes-Genis, A., Pascual-Figal, D.A.

“…The cardioprotective effects of metformin remain poorly defined. Interleukin (IL)-33/ST2L signaling is a novel cardioprotective pathway, which is antagonized…”
Get full text

Galectin-3 expression in cardiac remodeling after myocardial infarction by Sanchez-Mas, J, Lax, A, Asensio-Lopez, M.C, Fernandez-Del Palacio, M.J, Caballero, L, Garrido, I.P, Pastor, F, Januzzi, J.L, Pascual-Figal, D.A

Get full text

Galectina-3 as a biomarker of acute kidney injury risk in patients with decompensated heart failure by Sanchez-Serna, J, Martinez-Villanueva, M, Hernández-Vicente, Á, Asensio-Lopez, M C, Noguera, J A, Pascual-Figal, D A

“…INTRODUCTIONIn decompensated heart failure (HF), both acute kidney injury (AKI) and high Galectina-3 (Gal-3) levels have been associated with poorer outcomes…”
Get full text

Reformulated meat products protect against ischemia-induced cardiac damage by Asensio-Lopez, M C, Lax, A, Sanchez-Mas, J, Avellaneda, A, Planes, J, Pascual-Figal, D A

“…The protective effects of the antioxidants present in food are of great relevance for cardiovascular health. This study evaluates whether the extracts from…”
Get more information

Absence of cystatin C involvement in ventricular remodelling and heart failure by Pérez-Calvo, J I, Castiella Muruzábal, T, Búcar Barjud, M, Josa Laorden, C, Sánchez Marteles, M, Lacambra Blasco, I, Asensio López, M C, Pascual Figal, D A

“…UNLABELLEDCystatin C (CysC) is a protease encoded by housekeeping genes. Although its prognostic value in heart failure (HF) is well known, it is debatable…”
Get full text

Colchicine prevents accelerated atherosclerosis development in TET2-mutant clonal hematopoiesis by Zuriaga, M A, Yu, Z, Matesanz, N, Truong, B, Asensio-Lopez, M C, Uddin, M M, Nakao, T, Niroula, A, Zorita, V, Moro, R, Ebert, B L, Honigberg, M, Pacual-Figal, D, Natarajan, P, Fuster, J J

Get full text

P932Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKC/Gal-3 signaling pathway attenuates adverse cardiac fibrosis, following myocardial infarction by Asensio Lopez, M C, Lax, A M, Sanchez Perez, M T, Yassine, S, Hajjar, R, Pascual Figal, D A

Get full text

P936Yin-Yang 1 transcription factor modulates sST2 on adverse cardiac remodeling post-myocardial infarction by Lax, A M, Asensio Lopez, M C, Yassine, S, Hajjar, R, Januzzi, J L, Bayes Genis, A, Pascual Figal, D A

Get full text

Concentración de relaxina en pacientes con insuficiencia cardiaca aguda. Respuesta by Sánchez-Más, Jesus, Asensio-López, M. Carmen, Soriano-Filiu, Ángela, Pascual-Figal, Domingo

Get full text

Concentración de relaxina en pacientes con insuficiencia cardiaca aguda: comportamiento y determinantes clínicos by Martínez Solano, Jorge, Santos Mateo, Juan José, Sánchez-Más, Jesús, Sánchez, Juan, Asensio López, Mari Carmen, Pascual Figal, Domingo

Get full text

Valores seriados de galectina-3 a corto plazo en pacientes hospitalizados por insuficiencia cardiaca aguda by Sánchez-Serna, Juan, Pérez-Martínez, María T, Asensio-López, M. Carmen, Casas, Teresa, Noguera, José A, Pascual-Figal, Domingo A

Get full text

Galectin-3 signaling pathway is modulated by mineralocorticoid receptor antagonists in chronic heart failure by Asensio-Lopez, M. C., Lax, A., Pascual-Figal, D. A., Fernandez-Del Palacio, M. J., Santarelli, G., Abenza, S., Caballero, L., Perez-Martinez, M. T., Valdes-Chavarri, M., Sanchez-Mas, J.

Get full text

Mineralocorticoid receptor antagonists modulate ST2 signaling pathway in chronic heart failure by Asensio-Lopez, M. C., Sanchez-Mas, J., Pascual-Figal, D. A., Caballero, L., Fernandez Del Palacio, M. J., Santarelli, G., Abenza, S., Perez-Martinez, M. T., Valdes-Chavarri, M., Lax, A. M.

Get full text

Doxorubicin induced cardiotoxicity is attenuated by metformin through improvements in mitochondrial stabilization by Asensio-Lopez, M. C., Sanchez-Mas, J., Pascual-Figal, D. A., Abenza, S., Perez-Martinez, M. T., Pastor-Perez, F., Garrido-Bravo, I., Valdes-Chavarri, M., Lax, A. M.

Get full text

Myocardial scintigraphy with 123I-MIBG predicts appropriate ICD therapy in heart failure patients by Gonzalez Canovas, C., Perez Martinez, M. T., Mohamed, L., Garrido Bravo, I. P., Pastor Perez, F. J., Sanchez Mas, J., Lax Perez, A., Asensio Lopez, M. C., Claver Valderas, M. A., Pascual Figal, D. A.

Get full text

Absence of cystatin C involvement in ventricular remodelling and heart failure by Pérez-Calvo, J.I., Castiella Muruzábal, T., Búcar Barjud, M., Josa Laorden, C., Sánchez Marteles, M., Lacambra Blasco, I., Asensio López, M.C., Pascual Figal, D.A.

“…Cystatin C (CysC) is a protease encoded by housekeeping genes. Although its prognostic value in heart failure (HF) is well known, it is debatable whether this…”
Get full text

Galectina-3 as a biomarker of acute kidney injury risk in patients with decompensated heart failure by Sanchez-Serna, J., Martinez-Villanueva, M., Hernández-Vicente, Á., Asensio-Lopez, M.C., Noguera, J.A., Pascual-Figal, D.A.

“…In decompensated heart failure (HF), both acute kidney injury (AKI) and high Galectina-3 (Gal-3) levels have been associated with poorer outcomes. Plasma Gal-3…”
Get full text